Skip to content
COVID-19 was the third-leading cause of death in the United States between March 2020 and October 2021, according to a study of national death […]
US: COVID-19 was third-leading cause of death in 2020 and 2021 Read More »
We were always aware that mosquitoes can be choosy of the people they swarm around (while totally avoiding others) – but new research shows
Mosquitoes can sniff out mosquito-borne diseases, says study Read More »
The Food and Drug Administration (FDA) recommended COVID vaccine manufacturers modify the next round of COVID-19 booster shots to target the extremely contagious Omicron
FDA: Omicron variants should be included in fall boosters Read More »
The House Appropriations Committee is set to mark up today the fiscal year 2023 spending bill for Health and Human Services (HHS), which would
Healthcare spending bill draft includes many BIO requests Read More »
As monkeypox virus cases increase in the United States, the Biden administration will begin distributing the monkeypox vaccine around the country, focusing on persons
U.S. to distribute 1.6 million doses of monkeypox vaccine by year’s end Read More »
The Vaccine and Related Biological Products Advisory Committee (VRBPAC) of the Food and Drug Administration (FDA) voted 19-2 in favor of including Omicron variants
FDA advisers call for Omicron-specific boosters Read More »
The FDA’s Accelerated Approval pathway has assisted America’s biotech industry in making remarkable advances over the last 30 years—but it has come under political
Accelerated Approval is under political attack, experts say Read More »
New findings from one of the largest studies assessing the worldwide burden of sickle cell disease (SCD) were released just before World Sickle Cell
Multinational study highlights the burden of sickle cell disease Read More »
The Food and Drug Administration (FDA) will hold a meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Tuesday, June 28,
FDA advisory committee to discuss vaccines for COVID variants Read More »
On April 13, the U.S. Food and Drug Administration (FDA) released new draft guidance for industry on “creating strategies to recruit additional participants from underrepresented
BIO recommends improvements to FDA’s clinical trial diversity guidance Read More »
